Israel - anglès - Ministry of Health

novo nordisk ltd., israel - insulin degludec; liraglutide - solution for injection - insulin degludec 100 u/ml; liraglutide 3.6 mg/ml - insulin degludec and liraglutide - xultophy® is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to other oral medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control, and the population studied, see sections 4.4, 4.5 and 5.1

Singapur - anglès - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - liraglutide - injection, solution - liraglutide 6.0 mg/ml

Canadà - anglès - Health Canada

novo nordisk canada inc - insulin degludec; liraglutide - solution - 100unit; 3.6mg - insulin degludec 100unit; liraglutide 3.6mg - insulins

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - liraglutide -

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

novo nordisk ltd - insulin degludec; liraglutide - solution for injection - 100unit/1ml ; 3.6mg/1ml

Panamà - anglès - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

novo nordisk a/s - liraglutida - liraglutida....6 mg

Panamà - anglès - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

novo nordisk a/s - liraglutida - liraglutida....6.00 mg

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin degludec, quantity: 100 u/ml; liraglutide, quantity: 3.6 u/ml - solution - excipient ingredients: phenol; zinc; glycerol; water for injections; sodium hydroxide; hydrochloric acid - xultophy is indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control in combination with metformin, with or without other oral glucose-lowering medicinal products (see section 5.1 pharmacodynamic properties-clinical trials and section 4.4 special warnings and precautions for use? for available data on the different combinations).

Jordània - anglès - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع خوري - khoury drug store - liraglutide 6 mg/1ml - 6 mg/1ml

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

novo nordisk (pty) ltd û (rivonia) - injection - see ingredients - each 1,0 ml solution contains liraglutide 6,0 mg